References
- James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res 2001; 9(Suppl 4)228S–33S
- Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev 2005; 6: 11–12
- Erlanson-Albertsson C. How palatable food disrupts appetite regulation. Basic Clin Pharmacol Toxicol 2005; 97: 61–73
- Bell EA, Roe LS, Rolls BJ. Sensory-specific satiety is affected more by volume than by energy content of a liquid food. Physiol Behav 2003; 78: 593–600
- Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004; 59: 207–23
- Rubio MA, Gargallo M, Isabel Millan A, Moreno B. Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Public Health Nutr 2007; 10: 1200–5
- Goedecke JH, Barsdorf M, Beglinger C, Levitt NS, Lambert EV. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal. Int J Obes Relat Metab Disord 2003; 27: 1479–85
- Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 2002; 76: 266S–73S
- Green SM, Wales JK, Lawton CL, Blundell JE. Comparison of high-fat and high-carbohydrate foods in a meal or snack on short-term fat and energy intakes in obese women. Br J Nutr 2000; 84: 521–30
- Albertsson PA, Kohnke R, Emek SC, Mei J, Rehfeld JF, Akerlund HE, et al. Chloroplast membranes retard fat digestion and induce satiety: effect of biological membranes on pancreatic lipase/co-lipase. Biochem J 2007; 401: 727–33
- Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem 1998; 44: 991–1001
- Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004; 287: E297–304
- Beglinger C, Degen L. Fat in the intestine as a regulator of appetite: role of CCK. Physiol Behav 2004; 83: 617–21
- Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev 2005; 6: 297–306
- Savastano DM, Covasa M. Intestinal nutrients elicit satiation through concomitant activation of CCK(1) and 5-HT(3) receptors. Physiol Behav 2007; 92: 434–42
- Hopman WP, Jansen JB, Lamers CB. Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. Scand J Gastroenterol 1985; 20: 843–7
- Calam J, Bojarski JC, Springer CJ. Raw soya-bean flour increases cholecystokinin release in man. Br J Nutr 1987; 58: 175–9
- Jansen JB, Fried M, Hopman WP, Lamers CB, Meyer JH. Relation between gastric emptying of albumin-dextrose meals and cholecystokinin release in man. Dig Dis Sci 1994; 39: 571–6
- Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006; 89: 71–84
- Degen L, Drewe J, Piccoli F, Grani K, Oesch S, Bunea R, et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1391–9
- McDougall GJ, Stewart D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors 2005; 23: 189–95
- Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, Shibata H, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53: 4593–8
- Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, Wagenmakers AJ, et al. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 2007; 56: 168–76
- Carlsson M, Wessman Y, Almgren P, Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20: 1588–94